These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 3409248
1. Liposome-based therapy of human ovarian cancer: parameters determining potency of negatively charged and antibody-targeted liposomes. Straubinger RM, Lopez NG, Debs RJ, Hong K, Papahadjopoulos D. Cancer Res; 1988 Sep 15; 48(18):5237-45. PubMed ID: 3409248 [Abstract] [Full Text] [Related]
2. In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice. Nässander UK, Steerenberg PA, Poppe H, Storm G, Poels LG, De Jong WH, Crommelin DJ. Cancer Res; 1992 Feb 01; 52(3):646-53. PubMed ID: 1732053 [Abstract] [Full Text] [Related]
3. Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells. Matthay KK, Abai AM, Cobb S, Hong K, Papahadjopoulos D, Straubinger RM. Cancer Res; 1989 Sep 01; 49(17):4879-86. PubMed ID: 2788031 [Abstract] [Full Text] [Related]
4. Antibody-directed liposomes: comparison of various ligands for association, endocytosis, and drug delivery. Matthay KK, Heath TD, Badger CC, Bernstein ID, Papahadjopoulos D. Cancer Res; 1986 Oct 01; 46(10):4904-10. PubMed ID: 3756852 [Abstract] [Full Text] [Related]
5. Modulation of human ovarian tumor cell sensitivity to N-(phosphonacetyl)-L-aspartate (PALA) by liposome drug carriers. Sharma A, Straubinger NL, Straubinger RM. Pharm Res; 1993 Oct 01; 10(10):1434-41. PubMed ID: 8272404 [Abstract] [Full Text] [Related]
6. Antibody-directed targeting of liposomes to human cell lines: role of binding and internalization on growth inhibition. Berinstein N, Matthay KK, Papahadjopoulos D, Levy R, Sikic BI. Cancer Res; 1987 Nov 15; 47(22):5954-9. PubMed ID: 3664498 [Abstract] [Full Text] [Related]
7. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW. Cancer Res; 2000 Dec 15; 60(24):6950-7. PubMed ID: 11156395 [Abstract] [Full Text] [Related]
8. Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles. Matthay KK, Heath TD, Papahadjopoulos D. Cancer Res; 1984 May 15; 44(5):1880-6. PubMed ID: 6713389 [Abstract] [Full Text] [Related]
9. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Pietras RJ, Pegram MD, Finn RS, Maneval DA, Slamon DJ. Oncogene; 1998 Oct 29; 17(17):2235-49. PubMed ID: 9811454 [Abstract] [Full Text] [Related]
10. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells. Han I, Ling YH, al-Baker S, Khokhar AR, Perez-Soler R. Cancer Res; 1993 Oct 15; 53(20):4913-9. PubMed ID: 8402681 [Abstract] [Full Text] [Related]
11. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35. Elgqvist J, Andersson H, Bäck T, Hultborn R, Jensen H, Karlsson B, Lindegren S, Palm S, Warnhammar E, Jacobsson L. J Nucl Med; 2005 Nov 15; 46(11):1907-15. PubMed ID: 16269606 [Abstract] [Full Text] [Related]
12. Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes. van de Wetering P, Schuurmans-Nieuwenbroek NM, Hennink WE, Storm G. J Gene Med; 1999 Nov 15; 1(3):156-65. PubMed ID: 10738564 [Abstract] [Full Text] [Related]
13. Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro. Moradpour D, Compagnon B, Wilson BE, Nicolau C, Wands JR. Hepatology; 1995 Nov 15; 22(5):1527-37. PubMed ID: 7590672 [Abstract] [Full Text] [Related]
14. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Arlt MJ, Novak-Hofer I, Gast D, Gschwend V, Moldenhauer G, Grünberg J, Honer M, Schubiger PA, Altevogt P, Krüger A. Cancer Res; 2006 Jan 15; 66(2):936-43. PubMed ID: 16424028 [Abstract] [Full Text] [Related]
15. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs. Brignole C, Pastorino F, Marimpietri D, Pagnan G, Pistorio A, Allen TM, Pistoia V, Ponzoni M. J Natl Cancer Inst; 2004 Aug 04; 96(15):1171-80. PubMed ID: 15292389 [Abstract] [Full Text] [Related]
16. Application of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cells. Verbaan FJ, Klein Klouwenberg P, van Steenis JH, Snel CJ, Boerman O, Hennink WE, Storm G. Int J Pharm; 2005 Nov 04; 304(1-2):185-92. PubMed ID: 16129577 [Abstract] [Full Text] [Related]
17. Target therapy of ovarian carcinoma by monoclonal antibodies bearing chemical drugs entrapped in liposomes. Qian HN, Li WJ. Chin Med J (Engl); 1993 May 04; 106(5):343-7. PubMed ID: 8404276 [Abstract] [Full Text] [Related]
18. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposomes and adriamycin]. Li WJ, Qian HN, Lu WY. Zhonghua Yi Xue Za Zhi; 1994 Sep 04; 74(9):539-41, 582. PubMed ID: 7842351 [Abstract] [Full Text] [Related]
19. Increased efficiency of cisplatin-resistant cell lines to DNA-mediated gene transfer with cationic liposome. Sato T, Serikawa T, Sekine M, Aoki Y, Tanaka K. J Obstet Gynaecol Res; 2005 Oct 04; 31(5):368-74. PubMed ID: 16176502 [Abstract] [Full Text] [Related]
20. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. Ahmad I, Allen TM. Cancer Res; 1992 Sep 01; 52(17):4817-20. PubMed ID: 1511445 [Abstract] [Full Text] [Related] Page: [Next] [New Search]